Boise Cascade Shares Slide 23 as Major Investor Cuts Stake by 27 Million
Ashok Leyland Q4 Results Company Posts Record PAT of 1405 Crore Declares 250 Dividend
Pokmon Card Market Surges Nostalgia Speculation and Celebrity Influence Drive MillionDollar Sales
American Consumer Pessimism Persists as Inflation Geopolitical Risks and Trade Policies Weigh on Sentiment
Robinhood Introduces AI Agent Trading and Credit Card for Retail Investors
Inflation Pressures Broaden Beyond Energy Shelter Food and Services See Reacceleration
BIVI Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Drops
Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses
Chevron Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiencies
SAM Q1 2026 Earnings EPS Misses Estimates Stock Still Gains Ground
PRTC Q4 2024 Earnings EPS Misses Estimates as Pipeline Progress Continues
Vista Energy Q1 2026 Earnings Strong EPS Performance Amid Market Adjustment
Inspira Technologies IINN Holds Steady Near Key Resistance as Traders Await Catalyst
1stdibscom Inc DIBS Tests Support Zone After Recent Uptick
Apollomics Inc APLM Holds Steady Near Support Level as Consolidation Persists
Solitario Resources XPL Holds Steady Near Support as Trading Volume Remains Subdued
G WilliFood International WILC Gains 155 as Shares Test Key Resistance Zone
Nvidia Stock Dips After Earnings Release Why Some Market Participants May Be Overlooking the Bigger Picture
ABX Q1 2026 Earnings Narrow Miss on EPS as Shares Edge Higher
CEA Industries Warrant BNCWW Holds Steady at 003 Amid Flat Trading
UTZ Q1 2026 Earnings EPS Beat Fails to Lift Stock Amid Revenue Discrepancy
QT Imaging Q1 2026 Earnings Wide EPS Miss and No Revenue Reported Weigh on Investor Sentiment
CUK Q1 2026 Earnings EPS Meets Estimate Narrowly Stock Lifts 66
KDP Q1 2026 Earnings EPS Beats Estimates by 375 Stock Rises
IRON Q1 2026 Earnings Narrower Loss Beats Estimates as Disc Medicine Advances Clinical Pipeline
Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline
CMMB Q1 2026 Earnings Missed EPS Estimates but Stock Gains on Continued Pipeline Progress